Rules and Tools in the Battle against Superbugs - A call for integrated strategies and enhanced international collaboration to promote antimicrobial drug development
Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Standard
Rules and Tools in the Battle against Superbugs - A call for integrated strategies and enhanced international collaboration to promote antimicrobial drug development. / Minssen, Timo; Nordberg, Ana.
Infectious Diseases in the New Millennium: Legal and Ethical Challenges. red. / Mark Eccleston-Turner; Iain Brassington. Springer, 2020. s. 111-136.Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - Rules and Tools in the Battle against Superbugs - A call for integrated strategies and enhanced international collaboration to promote antimicrobial drug development
AU - Minssen, Timo
AU - Nordberg, Ana
PY - 2020/5/18
Y1 - 2020/5/18
N2 - The lack of treatments during the recent Ebola, Zika and COVID-19 outbreaks dramatically exposed the vulnerability of the global health system and the dire consequences thereof. But even where therapies against infectious diseases had been available, an additional threat has gained world-wide attention: antimicrobial resistance (AMR). A growing number of microbial organisms are becoming resistant to available drugs with increasingly diverse risks for a rapid global spreading of infections. Unfortunately, the traditional IP based innovation system and regulatory frameworks do not provide sufficient incentives to invest in the development of new antimicrobials. Hence, there are few new treatments in the pipeline to replace a growing number of ineffective drugs or problematic drug combinations. Repairing these broken economic incentives, improving access to and sustaining the effectiveness of antimicrobials is among the most important challenges in the health and life sciences. In this paper we emphasize that this goal can only be achieved through integrated strategies and a better global coordination of interdisciplinary multi-sector responses.
AB - The lack of treatments during the recent Ebola, Zika and COVID-19 outbreaks dramatically exposed the vulnerability of the global health system and the dire consequences thereof. But even where therapies against infectious diseases had been available, an additional threat has gained world-wide attention: antimicrobial resistance (AMR). A growing number of microbial organisms are becoming resistant to available drugs with increasingly diverse risks for a rapid global spreading of infections. Unfortunately, the traditional IP based innovation system and regulatory frameworks do not provide sufficient incentives to invest in the development of new antimicrobials. Hence, there are few new treatments in the pipeline to replace a growing number of ineffective drugs or problematic drug combinations. Repairing these broken economic incentives, improving access to and sustaining the effectiveness of antimicrobials is among the most important challenges in the health and life sciences. In this paper we emphasize that this goal can only be achieved through integrated strategies and a better global coordination of interdisciplinary multi-sector responses.
KW - Faculty of Law
KW - Sustainable Incentives, Regulatory Pathways, IPRs, Antimicrobials, resistance
KW - Accelerators
UR - https://www.springer.com/gp/book/9783030398187#aboutBook
U2 - 10.1007/978-3-030-39819-4_6
DO - 10.1007/978-3-030-39819-4_6
M3 - Book chapter
SN - 9783030398187
SP - 111
EP - 136
BT - Infectious Diseases in the New Millennium
A2 - Eccleston-Turner, Mark
A2 - Brassington, Iain
PB - Springer
ER -
ID: 182549807